(S)-2-(1-氧代-1-(4-(5-(三氟甲基)嘧啶-2-基)哌嗪-1-基)丙-2-基)2H-吲唑-7-甲酰胺
(S)-2-(1-Oxo-1-(4-(5-(trifluoromethyl)pyrimidin-2-yl)piperazin-1-yl)propan-2-yl)-2H-indazole-7-carboxamide
产品编号 :
Cas No. :
| 包装规格 |
纯度 |
目录价 |
会员专享价 |
库存 |
数量 |
| 1mg |
95% |
|
|
询价 |
|
| 5mg |
95% |
|
|
询价 |
|
| 10mg |
95% |
|
|
询价 |
|
| 25mg |
95% |
|
|
询价 |
|
| 50mg |
95% |
|
|
询价 |
|
| 100mg |
95% |
|
|
询价 |
|
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。
基础信息
CAS No. |
3024030-10-9 |
中文名称 |
(S)-2-(1-氧代-1-(4-(5-(三氟甲基)嘧啶-2-基)哌嗪-1-基)丙-2-基)2H-吲唑-7-甲酰胺 |
英文名称 |
(S)-2-(1-Oxo-1-(4-(5-(trifluoromethyl)pyrimidin-2-yl)piperazin-1-yl)propan-2-yl)-2H-indazole-7-carboxamide |
别名 |
PARP7-IN-17;(S)-2-(1-Oxo-1-(4-(5-(trifluoromethyl)pyrimidin-2-yl)piperazin-1-yl)propan-2-yl)-2H-indazole-7-carboxamide;2H-Indazole-7-carboxamide, 2-[(1S)-1-methyl-2-oxo-2-[4-[5-(trifluoromethyl)-2-pyrimidinyl]-1-piperazinyl]ethyl]- |
标准英文名 |
(S)-2-(1-oxo-1-(4-(5-(trifluoromethyl)pyrimidin-2-yl)piperazin-1-yl)propan-2-yl)-2H-indazole-7-carboxamide |
分子式 |
C20H20F3N7O2 |
分子量 |
447.42
|
精确分子量 |
447.16
|
SMILES |
C[C@@H](C(=O)N1CCN(C2=NC=C(C(F)(F)F)C=N2)CC1)N1C=C2C=CC=C(C(N)=O)C2=N1 |
标准SMILES |
C[C@@H](C(=O)N1CCN(CC1)C1N=CC(=CN=1)C(F)(F)F)N1C=C2C=CC=C(C(N)=O)C2=N1 |
用途 |
PARP7-IN-17 is a potent PARP7 inhibitor with an IC50 of 4.5 nM and exhibits antitumor activity; it is orally active. |
InChIKey |
ZXYKQNYSXHNQMV-LBPRGKRZSA-N |